Today, the news broke that the FDA has approved a drug that could extend the lives of some patients suffering from late-stage prostate cancer. For Wall Street, it’s a big story. For cancer researchers, it could represent a break-through. For some of today
Read More...
Read the complete post at http://www.healthbeatblog.com/2010/04/dendreon-hooks-the-big-one.html
Posted
Apr 29 2010, 02:34 PM
by
Health Beat